Results 231 to 240 of about 87,642 (357)
Summary Background Endoscopy, including tracheal mucus score (TMS) and bronchoalveolar lavage (BAL) fluid cytology, is commonly employed in the diagnosis of equine asthma (EA). Large‐scale studies comparing clinical signs, TMS and BAL cytology are warranted.
M. Larsen+5 more
wiley +1 more source
Abstract Background The diagnosis of mild–moderate equine asthma (MEA) can be confirmed by airway endoscopy, bronchoalveolar lavage fluid (BALf) cytology, and lung function evaluation by indirect pleural pressure measurement. Oscillometry is a promising pulmonary function test method, but its ability to detect subclinical airway obstruction has been ...
Chiara Maria Lo Feudo+5 more
wiley +1 more source
Should We Advance Our Understanding of Immunoglobulin E in Viral Immunity?
Immunoglobulin E has been extensively studied in allergies and parasitic diseases. Antigen‐specific IgE has been identified as part of the humoral response to viruses. This revision speculates on possible functionalities for IgE, such as neutralisation, cytotoxicity and immunopathology of viral diseases, and provide insights about gaps to fill in ...
Amanda Izeli Portilho+3 more
wiley +1 more source
Rapid onset of effect of benralizumab in a severe eosinophilic and allergic asthma patient with allergic bronchopulmonary aspergillosis [PDF]
Arvindran Alaga+2 more
openalex +1 more source
European Guideline (EuroGuiDerm) on atopic eczema: Living update
The updated guideline includes a new evidence‐based recommendation for the IL‐13 inhibitor lebrikizumab. In addition, the Janus kinase inhibitors baricitinib and abrocitinib, which were initially only approved for adult patients, are now also recommended for children from the age of 2 and adolescents from the age of 12, respectively.
A. Wollenberg+31 more
wiley +1 more source
Clinical Predictors of Longitudinal Respiratory Exacerbation Outcomes in Young Hospitalised Children
Clinical &Experimental Allergy, EarlyView.
Laura A. Coleman+8 more
wiley +1 more source
This large‐scale, propensity‐matched retrospective cohort study provides evidence that dupilumab treatment during pregnancy is not associated with an elevated risk of maternal adverse pregnancy outcomes (APOs). By utilizing real‐world data, it contributes critical insights into dupilumab's safety profile in pregnant women, addressing a crucial gap in ...
Sophie L. Preuß+9 more
wiley +1 more source
Efficacy and Safety of Mepolizumab in the Management of Severe Eosinophilic Asthma: A Systematic Review. [PDF]
Dighriri IM+14 more
europepmc +1 more source